Inventiva IVA
NASDAQ IVA
$3.46 -0.23 (-6.23%)
At close: Oct 1, 2026 · 4:00 PM EDT

Inventiva (IVA) Return on Equity [ROE] (2021)

Updated

Inventiva's Return on Equity [ROE] was -1991.44% in FY2023, down 1918.37 percentage points from -73.07% in FY2022.

Analysis

Inventiva (IVA) Return on Equity [ROE] (2021) Analysis & Trends

From FY2019 onward, Inventiva has reported Return on Equity [ROE] for 5 years.

  • Return on Equity [ROE] has now declined for three consecutive years, with a four-year change of -1934.62 percentage points (FY2019 to FY2023).
  • The FY2023 figure marks the lowest annual Return on Equity [ROE] in data going back to FY2019.
  • Per Business Quant data, Return on Equity [ROE] in earlier years was -73.07% in FY2022 (-22.47 pp), -50.61% in FY2021 (-6.31 pp), -44.29% in FY2020 (+12.53 pp) and -56.82% in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Inventiva 713.04 Mn 713.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -39.26%
API Access

Inventiva Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IVA&period=max&api_key=YOUR_API_KEY